Skip to content

TBPH · Theravance Biopharma, Inc.

Healthcare · 0.0% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 2 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive TBPH chart (by TradingView) loads here.

Our take

None of our tested rules has picked TBPH yet.

The 0–100 score for TBPH
Members see one number for how strongly these rules agree on TBPH, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of TBPH. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Congress purchases

Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Mar 24, 2025. Newest disclosure across this feed: Oct 15, 2026.

Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20260Partial; excluded
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 1; range: 0–1.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 20261Partial; excluded
Jun 29, 2026–Jul 26, 20261Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20261Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress purchases · Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–0.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress sales · Sparse history

Only 0 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–0.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20260Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

All 19 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Filed
  5. Filed
  6. Filed
  7. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Sep 15, 2026

  8. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Sep 15, 2026

  9. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Sep 15, 2026

  10. Filed
  11. Disclosed
    Eli Samaha · Sale

    Transaction dated Jul 7, 2026

  12. Disclosed
    Eli Samaha · Sale

    Transaction dated Jul 6, 2026

  13. Disclosed
    Eli Samaha · Sale

    Transaction dated Jun 30, 2026

  14. Disclosed
    Eli Samaha · Sale

    Transaction dated Jul 1, 2026

  15. Disclosed
    Eli Samaha · Sale

    Transaction dated Jun 29, 2026

  16. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Jun 15, 2026

  17. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Jun 15, 2026

  18. Disclosed
    Rhonda Farnum · Sale

    Transaction dated Jun 15, 2026

  19. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on TBPH disclosed in the last 90 days.

See every Congress trade on TBPH →

Company insiders

0 buys · 1 sell (3 filed lots) · $227K sold

  1. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$113Kdisclosed Sep 17 · filed 2 days after the trade
  2. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade
  3. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade
See every insider trade on TBPH →

Big holders (Schedule 13D / 13G): 1 filing in the last 90 days · newest: Weiss Asset Management LP (13D amendment), Sep 25, 2026 ↗

Filings & events

Company filings (8-K) 65

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0114
  • Quarterly or yearly results · item 2.0211
  • Shared information with investors · item 7.015
  • Signed a major agreement · item 1.013
  • Directors or officers joined, left or got new pay · item 5.023
  • Shareholder vote results · item 5.072

Filing red flags 18

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 9

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

1 in the last 90 days · 9 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 2

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 2 filings

Filed most: Weiss Asset Management LP (2)

Biggest named funds (13F)

The largest TBPH holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on TBPH

  1. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$113Kdisclosed Sep 17 · filed 2 days after the trade
  2. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade
  3. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$56.7Kdisclosed Sep 17 · filed 2 days after the trade
  4. ▼ SELLEli Samaha 10% ownerTBPH Theravance Biopharma, Inc.$95.5Kdisclosed Jul 8 · filed 1 day after the trade
  5. ▼ SELLEli Samaha 10% ownerTBPH Theravance Biopharma, Inc.$23.9Kdisclosed Jul 8 · filed 2 days after the trade
  6. ▼ SELLEli Samaha 10% ownerTBPH Theravance Biopharma, Inc.$429Kdisclosed Jul 1 · filed 1 day after the trade
  7. ▼ SELLEli Samaha 10% ownerTBPH Theravance Biopharma, Inc.$643Kdisclosed Jul 1 · filed the same day
  8. ▼ SELLEli Samaha 10% ownerTBPH Theravance Biopharma, Inc.$4.7Mdisclosed Jul 1 · filed 2 days after the trade
  9. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$54.6Kdisclosed Jun 17 · filed 2 days after the trade
  10. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$54.5Kdisclosed Jun 17 · filed 2 days after the trade
  11. ▼ SELLRhonda Farnum SVP, Comm & Medical AffairsTBPH Theravance Biopharma, Inc.$109Kdisclosed Jun 17 · filed 2 days after the trade
  12. ▼ SELLGeorge Whitesides Dem · House · CATBPH Theravance Biopharma, Inc.$15K–$50Kdisclosed Mar 24, 2025 · filed the same day
See the trades on TBPH in the feed →
People & votes

Which members of Congress traded TBPH, sponsored bills that touch it and voted on them — opens here.